ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $69,000 | -44.8% | 609 | -32.7% | 0.00% | -50.0% |
| Q4 2020 | $125,000 | -1.6% | 905 | -41.3% | 0.00% | -33.3% |
| Q3 2020 | $127,000 | -42.8% | 1,543 | -47.0% | 0.00% | -62.5% |
| Q3 2018 | $222,000 | +335.3% | 2,910 | +164.5% | 0.01% | +100.0% |
| Q4 2017 | $51,000 | -75.8% | 1,100 | -67.7% | 0.00% | -81.0% |
| Q2 2017 | $211,000 | +2.4% | 3,402 | +12.0% | 0.02% | -16.0% |
| Q1 2017 | $206,000 | +18.4% | 3,037 | +22.6% | 0.02% | 0.0% |
| Q4 2016 | $174,000 | +9.4% | 2,477 | +10.7% | 0.02% | +4.2% |
| Q3 2016 | $159,000 | +59.0% | 2,237 | +9.4% | 0.02% | +50.0% |
| Q2 2016 | $100,000 | – | 2,045 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |